Latest Breaking News On - Michael sassano - Page 3 : comparemela.com

SOMAÍ Pharmaceuticals Receives EU-GMP Certification and Raises €5 million

Somai GMP Facility Somai GMP Facility LISBON, Portugal, Sept. 01, 2023 (GLOBE NEWSWIRE) SOMAÍ Pharmaceuticals Unipessoal LDA (the “Company” or “SOMAÍ”), the largest European pharmaceutical cannabis product manufacturer, is pleased to announce that it has received authorisation for its facility located in Lisbon, Portugal from the Portuguese Health Authority INFRAMED (authorisation number 42/V01 de 25/08/2023). This authorisation permits the Company to manufacture, import, and export medicinal

SOMAÍ Pharmaceuticals Receives EU-GMP Certification and

LISBON, Portugal, Sept. 01, 2023 (GLOBE NEWSWIRE) SOMAÍ Pharmaceuticals Unipessoal LDA (the “Company” or “SOMAÍ”), the largest European pharmaceutical.

Somaí Pharmaceuticals Receives Eu-Gmp Certification And Raises €5 Million

From Manufacturing To Market: How This EU Pharma Co. Fast-Tracked Cannabis Production

European pharmaceutical cannabis product manufacturer SOMAÍ Pharmaceuticals Unipessoal LDA received authorization for its facility in Lisbon, Portugal, from the Portuguese Health Authority INFRAMED. Why It Matters This authorization allows the company to produce, import, and export medicinal cannabis products to numerous global markets.

What is next after the German house passes Cannabis reform? - WeedWorthy News Network